Glycosylated Haemoglobin: Determinants and Metabolic Correlates in T2DM in a Semi-Urban Nigeria Setting. A Prospective Study.
DOI:
https://doi.org/10.71637/tnhj.v25i2.1058Keywords:
hyperglycemia, poor diabetic control, glycated haemoglobin, insulin resistance, subclinical atherosclerosisAbstract
Background: The reliability of the glycosylated hemoglobin (HbA1c), documented to be the gold standard in the diagnosis and monitoring of diabetes mellitus, could be related to some medical conditions. The study determined the associates of the HbA1c in the diagnosis and monitoring of diabetes mellitus.
Methods: Data from 213 participants were analyzed in this prospective study to assess the determinants and correlates of HbA1c in a type 2 diabetic mellitus (T2DM) population. Independent associates of HbA1c were determined using regression analysis.
Results: The mean age of the 213 (50.23% females) participants was 66.9 ± 8.7 years. Majority were middle aged (60.10%), 158 (74.18%) were taking metformin. The mean HbA1c) was 5.89 ± 1.56%, it was higher in females, reduced with aging (p=0.08) but was positively related to the educational status, body mass index, waist hip ratio, waist circumference, and the blood pressure. Poor diabetes control was found in 25.82% of the participants, it was less common in men (p=0.09), elderly (p=0.001) and kidney dysfunction (p<0.001). The HbA1c was positively associated with the left ventricular hypertrophy (LVH), p=0.001, fasting insulin (p=0.003), insulin resistance (p=0.004).and was independently associated with LVH, hyperhomocysteinemia, insulin resistance and kidney function.
Conclusion: The control of diabetes mellitus was poor in women, in non-elderly, obesity, subclinical atherosclerosis and LVH. Using the HbA1c, early screening for at-risk population, and effective monitoring of diabetes patients is imperative to avert or minimize the deleterious effect of T2DM on the population, particularly the productive age group.
Downloads
References
1. Liu, J., Ren, ZH., Qiang, H. Wu J, Shen M, Zhang L, et al. Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention. BMC Public Health 2020; 20(1): 1415. [https://doi.org/10.1186/s12889-020-09502-x](https://doi.org/10.1186/s12889-020-09502-x)
2. Mohan V, Seedat YK, Pradeepa R. The Rising Burden of Diabetes and Hypertension in Southeast Asian and African Regions: Need for Effective Strategies for Prevention and Control in Primary Health Care Settings. Int J Hypertens. 2013; 2013: 409083. doi: 10.1155/2013/409083.
3. American Diabetes Association Professional Practice Committee; 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care 2022; 45 (Supplement_1): S17–S38. [https://doi.org/10.2337/dc22-S002](https://doi.org/10.2337/dc22-S002)
4. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care. 1987; 10(1):1-19. doi: 10.2337/diacare.10.1.1.
5. Alzahrani, BA, Salamatullah, HK., AIsharm, FS, Baljoon JM, Abukhodair AO, Ahmed ME, et al. The effect of different types of anemia on HbA1c levels in non-diabetics. BMC Endocr Disord 2023, 23(1): 24. [https://doi.org/10.1186/s12902-023-01280-y](https://doi.org/10.1186/s12902-023-01280-y)
6. D'Alessandro A, Mirasole C, Zolla L. Haemoglobin glycation (Hb1Ac) increases during red blood cell storage: a MALDI-TOF mass-spectrometry-based investigation. Vox Sang. 2013; 105(2):177-80. doi: 10.1111/vox.12029.
7. Critchley JA, Carey IM, Harris T, DeWilde S, Cook DG. Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People with Type 2 Diabetes in a Large Primary Care Cohort Study. Diabetes Care. 2019; 42(12):2237-2246. doi: 10.2337/dc19-0848.
8. Viskupicova J, Blaskovic D, Galiniak S, Soszyński M, Bartosz G, Horakova L, et al. Effect of high glucose concentrations on human erythrocytes in vitro. Redox Biol. 2015:381-387. doi: 10.1016/j.redox.2015.06.011.
9. Arkew M, Asmerom H, Tesfa T, Tsegaye S, Gemechu K, Bete T, et al. Red Blood Cell Parameters and Their Correlation with Glycemic Control Among Type 2 Diabetic Adult Patients in Eastern Ethiopia: A Comparative Cross-Sectional Study. Diabetes Metab Syndr Obes. 2022; 15:3499-3507. doi: 10.2147/DMSO.S386093.
10. Agu KC. Diabetes mellitus: a review of some of the prognostic markers of response to treatment and management. J Insul Resist. 2018; 3(1):1–10. doi: 10.4102/jir.v3i1.36
11. Olamoyegun MA, Alare K, Afolabi SA, Aderinto N, Adeyemi T. A systematic review and meta-analysis of the prevalence and risk factors of type 2 diabetes mellitus in Nigeria. Clin Diabetes Endocrinol. 2024; 10(1):43. doi: 10.1186/s40842-024-00209-1.
12. Bowring AL, Peeters A, Freak-Poll R, Lim MSC, Gouillou M, Hellard M. Measuring the accuracy of self-reported height and weight in a community-based sample of young people. BMC Med Res Methodol. 2012; 12:175.
13. International Diabetes Federation. IDF diabetes atlas | tenth edition [Internet]. 10th ed. 2022. [cited 2022 Jun 27]. Available from [https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf](https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf)
14. American Diabetes Association. (2020). Standards of Medical Care in Diabetes-2020. Diabetes Care, 43(Suppl 1), S1-S212. doi: 10.2337/dc20-S001
15. Langlois MR, Cobbaert C, Mallat Z, Boren J, Chapman MJ, Stein E, et al. Quantifying atherogenic lipoproteins for cardiovascular risk estimation. Nat Rev Cardiol. 2020;17(10):555-571. doi: 10.1038/s41569-020-0366-5
16. Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological and clinical implications. Diab Vasc Dis Res 2007; 4(1):13-9. doi: 10.3132/dvdr.2007.01
17. Wang Y, Li W, Wang J, Zhang Y, Liu X, Chen L, et al. Association between homocysteine and insulin resistance in patients with type 2 diabetes. J Diabetes Res. 2018:1-8. doi: 10.1155/2018/6583075
18. Chen L, Zhu W, Mai L, Zhang Y, Li X, Wang Y, et al. Serum uric acid is associated with insulin resistance and beta-cell dysfunction in patients with type 2 diabetes. J Diabetes Res. 2020; 2020:1-9. doi: 10.1155/2020/8898745
19. Li Z, Zhou Z, Li Y, Wang Y, Zhang Y, Liu X, et al. Association of atherogenic index of plasma with cardiovascular risk factors in adults. Lipids Health Dis. 2020; 19:1-9. doi: 10.1186/s12944-020-01234-6
20. Wang X, Zhang Y, Li X, Liu X, Wang Y, Zhang W, et al. Association of lipid ratios with cardiovascular risk in patients with hypertension. J Clin Hypertens (Greenwich). 2020; 22:53-59. doi: 10.1111/jch.13724
21. Wang S, Song S, Gao J, Duo Y, Gao Y, Fu Y, et al. Glycated haemoglobin variability and risk of renal function decline in type 2 diabetes mellitus: An updated systematic review and meta-analysis. Diabetes Obes Metab. 2024; 26(11):5167-5182. doi: 10.1111/dom.15861.
22. Nielsen AA, Petersen PH, Green A, Christensen C, Christensen H, Brandslund I. Changing from glucose to HbA1c for diabetes diagnosis: predictive values of one test and importance of analytical bias and imprecision. Clin Chem Lab Med. 2014; 52(7):1069–77. doi: 10.1515/cclm-2013-0337.
23. Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013;13(3):435-44. doi: 10.1007/s11892-013-0375-y.
24. Nascimento ALA, Guimarães AS, Rocha TDS, Goulart MOF, Xavier JA, Santos JCC. Structural changes in hemoglobin and glycation. Vitam Horm. 2024; 125:183-229. doi: 10.1016/bs.vh.2024.02.001.
25. Aepfelbacher FC, Yeon SB, Weinrauch LA, D'Elia J, Burger AJ. Improved glycemic control induces regression of left ventricular mass in patients with type 1 diabetes mellitus. Int J Cardiol. 2004;94(1):47-51. doi: 10.1016/j.ijcard.2003.04.012.
26. Hu C, Lin L, Zhu Y, Zhang Y, Wang S, Zhang J, et al. Association Between Age at Diagnosis of Type 2 Diabetes and Cardiovascular Diseases: A Nationwide, Population-Based, Cohort Study. Front Endocrinol (Lausanne). 2021; 12:717069. doi: 10.3389/fendo.2021.717069.
27. Haring R, Baumeister SE, Lieb W, von Sarnowski B, Völzke H, Felix SB, et al. Glycated hemoglobin as a marker of subclinical atherosclerosis and cardiac remodeling among non-diabetic adults from the general population. Diabetes Res Clin Pract. 2014;105(3):416-23. doi: 10.1016/j.diabres.2014.05.004
28. Yoshiuchi K, Matsuhisa M, Katakami N, Nakatani Y, Sakamoto K, Matsuoka T, et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J. 2008; 55(3):503-7. doi: 10.1507/endocrj.k07e-089
29. Ketema EB, Kibret KT. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Arch Public Health. 2015; 73:43. doi: 10.1186/s13690-015-0088-6.
30. Al-Hakeim HK, Abdulzahra MS. Correlation Between Glycated Hemoglobin and Homa Indices in Type 2 Diabetes Mellitus: Prediction of Beta-Cell Function from Glycated Hemoglobin J Medical Biochem 2015; 34: 191-199.
31. Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, et al. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care. 2011;34(7):1610-6. doi: 10.2337/dc11-0091.
32. Di Magno L, Di Pastena F, Bordone R, Coni S, Canettieri G. The Mechanism of Action of Biguanides: New Answers to a Complex Question. Cancers (Basel). 2022;14(13):3220. doi: 10.3390/cancers14133220.
Published
Issue
Section
License
Copyright (c) 2025 Oluwabukola Ayodele Ala, Peter Kehinde Uduagbamen, Opeyemi Oni, Olayemi Olanrewaju
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
